Mert Karakaya Selected Research

Mert Karakaya Research Topics

4	Ataxia (Dyssynergia) 12/2021 - 01/2018
3	Muscular Dystrophies (Muscular Dystrophy) 01/2017 - 01/2015
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Polyneuropathies (Polyneuropathy) 01/2020
1	Optic Atrophy 01/2020
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2020
1	Hyperekplexia 12/2019
1	Occipital horn syndrome 10/2019
1	Menkes Kinky Hair Syndrome (Menkes Disease) 10/2019
1	Atrophy 01/2019
1	Deafness (Deaf Mutism) 02/2018
1	Pain (Aches) 01/2018
1	of childhood progressive pseudorheumatoid Arthropathy 01/2018
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 11/2017
1	Lactic Acidosis 12/2016
1	Hypoglycemia (Reactive Hypoglycemia) 12/2016
1	Pyruvate Dehydrogenase Complex Deficiency Disease 12/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2016
1	Channelopathies 08/2016
1	Muscle Hypertonia 08/2016
1	Arthrogryposis 08/2016
1	Cardiomyopathies (Cardiomyopathy) 01/2016
1	Muscle Hypotonia (Hypotonia) 01/2016
1	Intellectual Disability (Idiocy) 01/2016
1	Ichthyosis (Xeroderma) 01/2016
1	Pruritus (Itching) 01/2016
1	Eczema 01/2016

3	ADP-ribosylarginine hydrolaseIBA 12/2021 - 01/2018
1	Vitamin B 6IBA 01/2020
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2020
1	Antisense OligonucleotidesIBA 01/2020
1	Copper-Transporting ATPasesIBA 10/2019
1	CarboxypeptidasesIBA 01/2019
1	cyclic hexapeptide(Phe-Phe-Trp-Lys-Thr-Phe)- somatostatin (CHP1)IBA 02/2018
1	Proteins (Proteins, Gene)FDA Link 02/2018
1	Tuberculin (PPD)IBA 01/2018
1	choline transporterIBA 11/2017
1	Laminin (Merosin)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 12/2016
1	Oxidoreductases (Dehydrogenase)IBA 12/2016
1	Pyruvic Acid (Pyruvate)IBA 12/2016
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2016
1	Ion Channels (Ion Channel)IBA 08/2016
1	Acetazolamide (Diamox)FDA LinkGeneric 08/2016
1	SodiumIBA 08/2016
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2016
1	Choline KinaseIBA 01/2016
1	DysferlinIBA 01/2015

2	Therapeutics 01/2020 - 08/2016
1	Drug Therapy (Chemotherapy) 12/2019